「place」の検索結果
35件：1～5件目を表示
-
ce successful completion of Phase III clinical trials in Japan, which consisted of the comparative (placebo-controlled) trial and the long-term administration trial. During the comparative trial, the ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
学会发表 | 研究与开发 | 千寿制药株式会社
羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study Tomoyuki Wada, PhD 1; Stephen C Pflugfelder, MD 2; Kazunori Omats...
https://www.senju.co.jp/chinese/rd/society/ -
Publications | Research & Development | SENJU Pharmaceutica
2025 Effects of dihydrocapsiateonsalivary secretion in healthy subjects:A randomized, double-blind, placebo-controlled, crossover study Keisuke Yoshida1, Ryuji Takeda2, and Osamu Sakai1. 1 Senju Pharm...
http://www.senju.co.jp/english/rd/thesis/ -
发表论文 | 研究与开发 | 千寿制药株式会社
2025 Effects of dihydrocapsiateonsalivary secretion in healthy subjects:A randomized, double-blind, placebo-controlled, crossover study Keisuke Yoshida1, Ryuji Takeda2, and Osamu Sakai1. 1 Senju Pharm...
http://www.senju.co.jp/chinese/rd/thesis/ -
学会发表 | 研究与开发 | 千寿制药株式会社
羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study Tomoyuki Wada, PhD 1; Stephen C Pflugfelder, MD 2; Kazunori Omats...
http://www.senju.co.jp/chinese/rd/society/